Character Biosciences has raised $93m in an oversubscribed Series B funding round to expedite the progression of precision therapies for degenerative eye conditions, beginning with age-related ...

Precision BioSciences (NASDAQ:DTIL) announced Wednesday that its experimental therapy PBGENE-DMD has received Rare Pediatric Disease Designation from the U.S. Food and Drug Administration for the ...

Familiarity with / experience in bacterial cell culture and protein expression methods. Familiarity with / experience in synchrotron-based structural biology methods. Experience / interest in Python ...

Kashiv Biosciences, LLC, a global leader in biopharmaceutical innovation, today announced that their abatacept biosimilar candidate, KSHB002, has succ ...

Neurocrine Biosciences Inc is a research-based pharmaceutical company advancing drug candidates in the central nervous system and endocrine-related categories.

SNAP Biosciences and Monarch Therapeutics announce a licensing deal for advanced NK cell therapies using small molecule adaptors.

Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nsPFA™) technology, today an ...

Astellas Enters Exclusive License Agreement with Evopoint Biosciences for XNW27011, a Novel Clinical-stage Antibody-Drug Conjugate Targeting CLDN18.2 ...

Tom Polen emphasized several key updates, including the planned separation of BD’s Biosciences and Diagnostic Solutions businesses, which aims to create two strategically aligned entities. He ...